What does the evidence say about Methylsulfonylmethane Joint Pain Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Methylsulfonylmethane Joint Pain Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - There is a paucity of evidence regarding whether the effective outcomes of arthrocentesis in the management of temporomandibular joint disorders (TMJD) result from its use as a single treatment or in association with adjunctive therapy. [Simplot TM (2025); evidence level 1] - The study aimed to compare arthrocentesis alone (ACA) and arthrocentesis (AC) associated with adjunctive therapy (AAAT) to determine the most effective treatment strategy. [Simplot TM (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.